PA
PAYS icon

PharVision Advisers’s Paysign PAYS Stock Holding History

PharVision Advisers’s Portfolio PAYS Stock Details PAYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-86,588
Closed -$446K – 497
2025
Q4 		$446K Buy
86,588
+34,607
+67% +$187K 0.23% 74
2025
Q3 		$327K Buy
+51,981
New +$332K 0.18% 177

Other funds holding PAYS

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's PAYS Position: Q1 2026 in Review

PharVision Advisers sold out of Paysign (PAYS) in Q1 2026, closing a stake of 86,588 shares — an estimated $446K sold.

PharVision Advisers first reported a position in PAYS in Q3 2025 and held it in 2 quarters. The position peaked at $446K in Q4 2025. 111 funds tracked by Wall St. Rank hold PAYS as of Q1 2026.

  • PharVision Advisers reported no remaining Paysign position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 86,588 Paysign shares in Q1 2026, an estimated $446K.
  • PharVision Advisers first reported a position in Paysign in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Paysign position peaked at $446K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Paysign as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.